Public-registry site landscape for NCT07720284, a High-risk Muscle Invasive Urothelial Carcinoma study sponsored by AstraZeneca. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07720284 (registry record) |
| Sponsor | AstraZeneca |
| Condition(s) | High-risk Muscle Invasive Urothelial Carcinoma |
| Phase | PHASE3 |
| Listed sites | 160 |
| Site countries | United States, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Poland, South Korea |
Eichor generates a preliminary site-risk snapshot for NCT07720284 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →